Testicular cancer developed in a chronic myeloid leukemia patient with a continued complete cytogenetic and molecular response to imatinib. A case report and review of the literature

Leuk Res. 2010 Sep;34(9):e229-31. doi: 10.1016/j.leukres.2010.03.019. Epub 2010 Mar 31.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Review

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Benzamides
  • Humans
  • Imatinib Mesylate
  • Karyotyping
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
  • Male
  • Middle Aged
  • Neoplasms, Second Primary / complications*
  • Neoplasms, Second Primary / drug therapy
  • Piperazines / therapeutic use*
  • Pyrimidines / therapeutic use*
  • Testicular Neoplasms / complications*
  • Testicular Neoplasms / drug therapy
  • Young Adult

Substances

  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate